Predictors for the white coat effect in general practice patients with suspected and treated hypertension

被引:0
|
作者
Lindbæk, M
Sandvik, E
Liodden, K
Mjell, J
Ravnsborg-Gjertsen, K
机构
[1] Univ Oslo, Dept Gen Practice & Community Med, N-0318 Oslo, Norway
[2] Stovner Hlth Care Ctr, Oslo, Norway
[3] Stokke Doctors Ctr, Stokke, Norway
来源
BRITISH JOURNAL OF GENERAL PRACTICE | 2003年 / 53卷 / 495期
关键词
ambulatory blood pressure monitoring; white coat hypertension; hypertension;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Ambulatory blood pressure monitoring was introduced more than 40 years ago and is accepted as a clinically useful method to evaluate the white coat effect in patients with suspected and established hypertension. Aim. To study the differences between blood pressure readings taken in the physician's office in the primary healthcare setting, and ambulatory readings, and to find possible predictors Design of study Prospective study Setting. Two primary healthcare centres in Norway Method: The study included 221 patients, 107 of whom were on antihypertensive treatment, and 114 of whom were under investigation for possible hypertension. Differences between blood pressure readings taken in the physician's office and ambulatory readings were calculated Independent predictors for the white coat effect were calculated using linear regression analysis. Results. The difference between blood pressure readings taken in the office and ambulatory readings was 2 7 mmHg systolic and I I mmHg diastolic. For the systolic readings, the following factors were independent predictors of the amount of the white coat effect. mean blood pressure, age, history of smoking family history of cardiovascular disease, and antihypertensive treatment. For the diastolic readings, they were. mean blood pressure, history of smoking, and sex of the patient (with this being most significant for women). Conclusion: Ambulatory blood pressure measurement is of significant value in identifying patients with white coat hypertension. It can be an important supplement for use in the diagnosis and follow-up of patients with hypertension in general practice.
引用
收藏
页码:790 / 793
页数:4
相关论文
共 50 条
  • [31] Cilnidipine in management of patients with uncontrolled hypertension and white-coat effect
    Mansour, George
    Mansour, Janette
    CURRENT HYPERTENSION REPORTS, 2007, 9 (06) : 489 - 490
  • [32] Does Pseudoresistant Hypertension Attributed to White-Coat Effect Define Subjects With "Treated Normalized Hypertension?"
    Franklin, Stanley S.
    Thijs, Lutgarde
    Staessen, Jan A.
    HYPERTENSION, 2012, 59 (05) : E43 - E43
  • [33] WHITE COAT EFFECT IN TREATED HYPERTENSIVE PATIENTS - SEX-DIFFERENCES
    MYERS, MG
    REEVES, RA
    JOURNAL OF HUMAN HYPERTENSION, 1995, 9 (09) : 729 - 733
  • [34] White-coat effect in normotension and hypertension
    Zakopoulos, NA
    Kotsis, VT
    Pitiriga, VC
    Toumanidis, ST
    Lekakis, JP
    Nanas, SN
    Vemmos, KN
    Stamatelopoulos, SF
    Moulopoulos, SD
    BLOOD PRESSURE MONITORING, 2002, 7 (05) : 271 - 276
  • [35] Endothelial dysfunction in patients with white coat hypertension
    E Çoban
    A Timuraǧaoǧlu
    M Özdoǧan
    Journal of Human Hypertension, 2004, 18 : 71 - 72
  • [36] Endothelial dysfunction in patients with white coat hypertension
    Çoban, E
    Timuragaoglu, A
    Özdogan, M
    JOURNAL OF HUMAN HYPERTENSION, 2004, 18 (01) : 71 - 72
  • [37] White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes
    Bursztyn, Michael
    Ben-Dov, Iddo Z.
    DIABETES CARE, 2009, 32 : S310 - S313
  • [38] The White Coat Effect (WCE) in treated hypertensives
    Aksoy, I
    Lenders, J
    Deinum, J
    Thien, T
    JOURNAL OF HYPERTENSION, 2003, 21 : S25 - S26
  • [39] Should White-Coat Hypertension in Diabetes Be Treated? Pro
    Mancia, Giuseppe
    Sega, Roberto
    Bombelli, Michele
    Quarti-Trevano, Fosca
    Facchetti, Rita
    Grassi, Guido
    DIABETES CARE, 2009, 32 : S305 - S309
  • [40] Predictors of isolated clinic (white-coat) hypertension in subjects with stage I hypertension
    Verdecchia, P
    Palatini, P
    Schillaci, G
    Mormino, P
    Porcellati, C
    Pessina, A
    JOURNAL OF HYPERTENSION, 2000, 18 : S9 - S9